These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


68 related items for PubMed ID: 14579277

  • 21. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K, Abraham D, Sioud M, Aharinejad S.
    Cancer Res; 2007 Feb 01; 67(3):1038-45. PubMed ID: 17283136
    [Abstract] [Full Text] [Related]

  • 22. CSF-1 as a regulator of macrophage activation and immune responses.
    Sweet MJ, Hume DA.
    Arch Immunol Ther Exp (Warsz); 2003 Feb 01; 51(3):169-77. PubMed ID: 12894871
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, Hertzog PJ, Hamilton JA.
    Bone; 2007 Feb 01; 40(2):323-36. PubMed ID: 17055352
    [Abstract] [Full Text] [Related]

  • 25. Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y, Kobayashi M, Nakata H, Kubota T, Saito T, Bandobashi K, Taguchi H.
    Int J Mol Med; 2005 Nov 01; 16(5):873-81. PubMed ID: 16211258
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K, Yamamura M, Iwahashi M, Otsuka F, Yamana J, Sunahori K, Kawashima M, Yamada M, Makino H.
    Arthritis Res Ther; 2006 Nov 01; 8(4):R126. PubMed ID: 16859503
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. IL-2 induction by simian immunodeficiency virus involves MAP kinase signaling but is independent of calcineurin/NF-AT activity.
    Muckenfuss H, Hamdorf M, Avots A, Sanzenbacher R, Tschulena U, Cichutek K, Flory E.
    Mol Immunol; 2006 Mar 01; 43(8):1172-82. PubMed ID: 16125242
    [Abstract] [Full Text] [Related]

  • 31. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ.
    J Leukoc Biol; 2006 Jan 01; 79(1):133-9. PubMed ID: 16275889
    [Abstract] [Full Text] [Related]

  • 32. Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.
    Brummer E, Gilmore GL, Shadduck RK, Stevens DA.
    Cell Immunol; 1998 Nov 01; 189(2):144-8. PubMed ID: 9790728
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation.
    Valledor AF, Comalada M, Xaus J, Celada A.
    J Biol Chem; 2000 Mar 10; 275(10):7403-9. PubMed ID: 10702314
    [Abstract] [Full Text] [Related]

  • 35. Biological characterization of uncleavable plasma membrane-anchored human macrophage colony-stimulating factor.
    Deng P, Wang YL, Shahbazian VL, Pattengale PK.
    Biochem Biophys Res Commun; 2000 Sep 16; 276(1):304-11. PubMed ID: 11006122
    [Abstract] [Full Text] [Related]

  • 36. Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.
    Zenke G, Strittmatter U, Fuchs S, Quesniaux VF, Brinkmann V, Schuler W, Zurini M, Enz A, Billich A, Sanglier JJ, Fehr T.
    J Immunol; 2001 Jun 15; 166(12):7165-71. PubMed ID: 11390463
    [Abstract] [Full Text] [Related]

  • 37. IFN-{gamma}-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation.
    Valledor AF, Arpa L, Sánchez-Tilló E, Comalada M, Casals C, Xaus J, Caelles C, Lloberas J, Celada A.
    Blood; 2008 Oct 15; 112(8):3274-82. PubMed ID: 18682602
    [Abstract] [Full Text] [Related]

  • 38. [Effects of calcium blockers and calmodulin inhibitors on the proliferation of fibroblast in alveolar macrophage condition medium].
    Zhu YL, Zhu YJ, Guo ZJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec 15; 16(6):338-41, 373-4. PubMed ID: 8033230
    [Abstract] [Full Text] [Related]

  • 39. cAMP modulates macrophage development by suppressing M-CSF-induced MAPKs activation.
    Zhu N, Cui J, Qiao C, Li Y, Ma Y, Zhang J, Shen B.
    Cell Mol Immunol; 2008 Apr 15; 5(2):153-7. PubMed ID: 18445346
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.
    Zhang LH, Youn HD, Liu JO.
    J Biol Chem; 2001 Nov 23; 276(47):43534-40. PubMed ID: 11557753
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.